Camp4 Therapeutics Corp
Develops RNA-based therapeutics to amplify protein expression for genetic diseases.
CAMP | US
Overview
Corporate Details
- ISIN(s):
- US13463J1016
- LEI:
- Country:
- United States of America
- Address:
- ONE KENDALL SQUARE, 2139 CAMBRIDGE
- Website:
- https://www.camp4tx.com/
- Sector:
- Manufacturing
Description
Camp4 Therapeutics Corp. is a clinical-stage biopharmaceutical company that develops programmable therapeutics for a range of genetic diseases. The company pioneers an approach centered on regulatory RNA (regRNA) to modulate gene expression and amplify the production of healthy proteins. Its core technology involves RNA Actuators, a class of antisense oligonucleotides (ASOs), which are designed to restore protein levels to a healthy range. Camp4 utilizes its proprietary RNA Actuating Platform (RAP) to discover and advance its pipeline of potential disease-modifying treatments, with a focus on rare genetic conditions where upregulating protein expression may offer therapeutic benefits.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Camp4 Therapeutics Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Camp4 Therapeutics Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Camp4 Therapeutics Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
